NIMH Researchers find biomarker to accurately prescribe antidepressants

Washington, DC (GroundReport) – According to researchers at the National Institute of Mental Health, images of the brain’s fastest signals reveal an electromagnetic marker that predicts a patient’s response to a fast-acting antidepressant.

Carlos Zarate, M.D., of the National Institute of Mental Health (NIMH), Mood and Anxiety Disorders Program. was quoted as saying, "Such biomarkers that identify who will benefit from a new class of antidepressants could someday minimize trial-and-error prescribing and speed delivery of care for what can be a life-threatening illness."